Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring

Launched by ODENSE UNIVERSITY HOSPITAL · Jun 18, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring the benefits of a continuous glucose monitoring system, which uses a sensor to keep track of blood sugar levels, compared to the traditional method of checking blood sugar with a fingerstick. The study focuses on adult patients in surgical wards who need regular blood sugar checks due to diabetes or surgery. Researchers want to find out if the continuous monitoring system is more effective in managing blood sugar levels, improving patient satisfaction, and reducing the workload for nursing staff. They also aim to see if this method can help prevent complications and shorten hospital stays.

To participate in the trial, individuals must be at least 18 years old, hospitalized in a surgical ward, and require blood sugar measurements at least five times a day for at least three days. They should be able to communicate in Danish and have given consent to join the study. Patients with diabetes or those undergoing certain surgeries related to the pancreas are eligible, while those with cognitive impairments or already using a continuous glucose monitoring system are excluded. Participants can expect to have their blood sugar monitored using both methods during their hospital stay, and their experiences will help improve future diabetes care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Hospitalized patients (≥ 18 years old) in surgical wards
• • Glucose measurements at least 4 times (OUH) and 3 times (SUH) daily for at least three days, prescribed by surgeon
• • Expected hospitalization for at least three days
• • Communicates in Danish
• • Signed a declaration of consent to study participation
• • At risk of hypo- and hyperglycemia (with or without a diabetes diagnosis)
• • Specific for substudy 4 inclusion criteria as above with the following add on: Patients being treated with insulin at discharge and patients residing within the OUH admission area.
• Exclusion Criteria:
• • Cognitively impaired patients
• • Indication for glucose monitoring solely because of parenteral nutrition treatment
• • Patients admitted with a CGMS
• • Patients from the point-of-care fingerstick capillary glucose monitoring group cannot be included in the continuous glucose monitoring system group
• • Eligibility criteria solely for substudy 7
• Inclusion Criteria:
• • Nursing staff with at least one month of experience with both point-of-care fingerstick capillary glucose monitoring and continuous glucose monitoring system and are registered nurses or certified nursing assistants